SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001469
Filing Date
2024-01-17
Accepted
2024-01-17 07:56:06
Documents
13
Period of Report
2024-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240116_8k.htm   iXBRL 8-K 37392
  Complete submission text file 0001437749-24-001469.txt   172626

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20240112.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240112_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240112_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240112_pre.xml EX-101.PRE 11584
7 EXTRACTED XBRL INSTANCE DOCUMENT wint20240116_8k_htm.xml XML 2563
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 24536748
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)